AE Wealth Management »

Supernus Pharmaceuticals shares owned by AE Wealth Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by AE Wealth Management from 13F filings

Historical chart of AE Wealth Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by AE Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by AE Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $429k 15k 28.71

More positions owned by AE Wealth Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Ishares Tr Rus Tp200 Gr Etf (IWY)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Sustainabilty (DFSU)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)
Aim Etf Products Trust Us Lrgcp B20 Jan (JANW)
Vanguard Index Fds Growth Etf (VUG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Rus Tp200 Vl Etf (IWX)

View all positions for AE Wealth Management

Top funds holding Supernus Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Jennifer Ranahan
Congress Asset Management
Ashford Capital Management
Victory Capital Management
Charles Schwab Investment Management
Rice Hall James & Associates
T. Rowe Price Associates
Bank of New York Mellon
Bank of America Corporation
Tributary Capital Management
Mutual Of America Capital Management
Principal Financial Group
Norges Bank Investment Management

View all funds holding Supernus Pharmaceuticals